Clinical Trial Update: CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CetuGEX to cetuximab in head and neck squamous cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CetuGEX
• Cetuximab (cetuximab)

Snippet

Sponsor: Glycotope GmbH | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2021-11-02